| Bioactivity | Pred17 is a potent EGFR inhibitor. Pred17 has the potential for the research of lung cancer[1]. |
| Formula | C27H20BrN3O |
| Molar Mass | 482.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Moussaoui M, et al. Design and Optimization of Quinazoline Derivatives as Potent EGFR Inhibitors for Lung Cancer Treatment: A Comprehensive QSAR, ADMET, and Molecular Modeling Investigation. ACS Omega. 2024 Nov 8;9(46):45842-45857. |